Navigation Links
Cheetah Medical Announces New Management Team
Date:6/4/2013

NEWTON, Mass., June 4, 2013 /PRNewswire/ -- Cheetah Medical Inc., which developed and markets NICOM®, the revolutionary Non-invasive Hemodynamic Monitoring System, today announced the appointment of Chris Hutchison as President and CEO and William T. Denman , MBChB, FRCA as Chief Medical Officer.  Concurrently, the Company announced the completion of a $14.5 million financing with a prestigious group of investors including Springfield Investments, Ascension Health Ventures, MVM Life Science Partners and Robert Bosch Venture Capital.

The proceeds will be used to accelerate commercialization of NICOM in the U.S. and internationally.  NICOM is currently deployed for Goal Directed Fluid Management in over 100 hospitals in the U.S. and is widely used in OUS markets.

Mr. Hutchison has spent over 25 years in the medical device industry and has extensive general management experience, including commercializing early stage technologies in the U.S., Europe and Emerging Markets.  Prior to Cheetah he spent seven years with Covidien where he served as a General Manager in the Respiratory & Monitoring Systems and Vascular Therapies divisions.  Prior to joining Covidien, Mr. Hutchison was a U.S. Divisional President at Smiths Medical.

"There is a real need in many hospital settings for early, accurate and non-invasive hemodynamic information to better inform clinical decision making.  Since it is noninvasive, NICOM is easy and quick to deploy in critical care settings and eliminates many risks associated with older invasive methods.  He continued, "We believe that NICOM improves patient outcomes, and drives favorable healthcare economics, both of which are key considerations in the current healthcare environment."

"I am pleased to have "Pepper" Denman as our Chief Medical Officer.  He has had a distinguished career as a clinician specializing in anesthesiology, as a researcher, as an Assistant Professor at the Harvard Medical School, and was a healthcare executive for over nine years with Covidien and GE Healthcare.  He has a broad knowledge of fluid management and the critical role that it plays in patient care.

About Cheetah Medical
Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the Company's patented and proprietary BIOREACTANCE® technology.  Clinicians use the NICOM for noninvasive, Goal Directed Fluid Management in critical and non-critical clinical environments.  NICOM is FDA cleared and has received a CE Mark.

Founded in 2000, Cheetah medical is privately held and is headquartered in Vancouver, WA.  For more information about Cheetah Medical, please visit our website at www.cheetah-medical.com.Company Contact: Media Contact:Jim Wagner

Steve Sandler(617) 947-8946

(508) 358-7206 ext. 202jim.wagner@cheetah-medical.comssandler@vmark.net


'/>"/>
SOURCE Cheetah Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. seca Launches the seca mBCA 514 - medical Body Composition Analyzer
2. Kettering Medical Center Acquires Elektas Versa HD Radiotherapy System
3. Solta Medical Announces Isolaz 2 Acne System
4. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
5. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
6. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
7. CCS Medical Announces Enhanced Product Formulary
8. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
9. Hair Restoration Center Announces New Female Medical Hair Restoration
10. Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer
11. Medical Device & Implants, LLC to exhibit at MD&M East 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid ... Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, and ... regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist and ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Alert Sentry ... of MPERS (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These ... market. The first of their kind, the iSAFE and iSAFE Plus offer direct GPS ...
Breaking Medicine News(10 mins):